Novartis International AG - New Novartis analyses at AAN show siponimod's efficacy on disability and cognition in secondary progressive MS patients
Novartis International AG / New Novartis analyses at AAN show siponimod's efficacy on disability and cognition in secondary progressive MS patients . Processed ...Articles similaires à Novartis International AG - New Novartis analyses at AAN show siponimod's efficacy on disability and cognition in secondary progressive MS patients
• Sources :
• Mots clés :
• Participer :
• Suivre l'actualité :
BACK TO TOP
